Interní Med. 2007; 9(6): 288-291
Health risk reduction of medical aplication of phatalates (DEHP)
- Odborný konzultant v oblasti zdravotních a ekologických rizik, Plzeň
Health risk of phtalates (especially DEHP) in connection with health care and possibilities of their reduction. Phtalates are esters of phtalic acid, a group of massively synthesized chemical substances with the ability of accumulation in biological tissues. Toxicity of phtalates for people and animals raise an anxiety, in spite of the fact that precise mechanisms of toxicity and its level may differ in individual phtalates. Medical care belongs to an important source of exposition of phtalates, mainly di (2-etylhexyl) phtalate (DEHP). Sources of phtalates are medical utilities produced from polyvinylchloride (PVC), e.g. infusion and transfusion sets, sets for haemodialysis and parenteral nutrition, oxygen masks etc. Safer alternatives from material not containing phtalates are commercially available, e.g. from polypropylen (PP), polyetylen (PE), etylen vinyl acetate (EVA) or silicone. A number of medical institutions accept policy of patient protection from a useless exposition of phtalates, mainly DEHP.
Keywords: phtalates, DEHP, toxicity, exposition, health risks, regulation
Published: November 9, 2007 Show citation
References
- Arcadi RA, at al. Oral toxicity of DEHP during pregnancy and suckling in the Long-Evans rat. Food and Chemical Toxicology, 1998; 36: 963-970.
Go to original source... 
Go to PubMed... - Crocker J, at al. Effects of chronic phthalate exposure on the kidney. Journal of Toxicology and Environmental Health, 1988; 23: 433-444. Go to original source... Go to PubMed...
- Davis BJ, at al. Di-(2-ethylhexyl) phthalate suppresses estradiol and ovulation in cycling rats. Toxicol Appl Pharmacol, 1994; 128: 216-223. Go to original source... Go to PubMed...
- Doull J, et al. A cancer risk assessment of di (2-ethylhexyl) phthalate: application of the new U.S. EPA risk assessment guidelines. Regulatory Toxicology and Pharmacology, 1999; 29: 327-357. Go to original source... Go to PubMed...
- Gray E, et. al. Administration of potentially antiandrogenic pesticides (procymidone, linuron, iprodione, chlozolinate, p,p'-DDE, and ketoconazole) and toxic substances (dibutyl- and diethylhexyl phthalate, PCB 169, and ethane dimethane suphonate) during sexual differentiation produces diverse profiles of reproductive malformations in the rat. Toxicology and Industrial Health, 1999; 15: 94-118. Go to original source...
- Kevy S, at al. Hepatic effects of a phthalate ester plasticizer leached from poly(vinyl chloride) blood bags following transfusion. Environmental Health Perspectives, 1982; 45: 57-64. Go to original source... Go to PubMed...
- Koch HM, et al. An estimation of the daily intake of di(2-ethylhexyl) phthalate (DEHP) and other phthalates in the general population. Int. J. Hyg. Environ. Health, 2003; 206: 77-83. Go to original source... Go to PubMed...
- Lamb JC, at al. Reproductive effects of four phthalic acid esters in the mouse. Toxicol. Appl. Pharmacol, 1987; 88: 255-269. Go to original source... Go to PubMed...
- Latini G, et al. In utero exposure to di-(2-ethylhexyl) phthalate and duration of human pregnancy. Environmental Health Perspectives, 2003; 111: 1783-1785. Go to original source... Go to PubMed...
- Latini G, et al. Materials degradation in endotracheal tubes: a potential contributor to bronchopulmonary disease (letter). Acta Paeditr, 1999; 88: 1174-1175. Go to original source... Go to PubMed...
- Li LH. A single dose of Di-(2-ethylhexyl) phthalate in neonatal rats alters gonocytes, reduces sertoli cell proliferation, and decreases cyclin D2 expression. Toxicol Appl Pharmacol, 2000; 166: 222-229. Go to original source... Go to PubMed...
- Moore RW, et al. Abnormalities of sexual development in male rats with in utero and lactational exposure to the antiandrogenic plasticizer di92-ethylhexyl) phthalate. Environmental Health Perspectives, 2001; 109: 229-237. Go to original source... Go to PubMed...
- National Toxicology Program (NTP), Center for the Evaluation of Risks to Human Reproduction (CERHR). NTP CERHR Expert Panel Report on Di (2-ethylhexyl) Phthalate. Alexandria, 2001.
- Pearson S, et al. Leaching of diethylhexyl phthalate from polyvinyl chloride containers by selected drugs and formulation components. American Journal of Hosp Pharm, 1993; 50: 1405-1409. Go to original source...
- Petersen J, at al. Plasticizers in total diet samples, baby food, and infant formulae. Food Additives and Contaminants, 2000; 17 (2): 133-141. Go to original source... Go to PubMed...
- Plonait SL, et al. Exposure of newborn infants to di-(2-ethylhexyl) phthalate and 2-ethylhexanoic acid following exchange transfusion with polyvinylchloride catheters. Transfusion, 1993; 33: 598-605. Go to original source... Go to PubMed...
- Poon R, at al. Subchronic oral toxicity of di-n-ocytl phthalate and DEHP in the rat. Food Chemistry and Toxicology, 1997; 35: 225-239. Go to original source... Go to PubMed...
- Rock G, et al. Hypotension and cardiac arrest in rats after infusion of mono(2-ethylhexyl) phthalate (MEHP) a contaminant of stored blood. The New England Journal of Medicine, 1987; 316: 1218-1219. Go to original source... Go to PubMed...
- Sjöberg P, et al. Exposure of newborn infants to plasticizers: Plasma levels of di-(2-ethylhexyl) phthalate and mono-(2-ethylhexyl) phthalate during exchange transfusion. Transfusion, 1985; 25 (5): 424-428. Go to original source... Go to PubMed...
- HCWH: Preventing Harm from Phthalates, Avoiding PVC in Hospitals, Praha, 2004.